𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2

✍ Scribed by Jun-ichi Sasaki; Fumio Konishi; Yutaka J. Kawamura; Toshihiro Kai; Osamu Takata; Toshihiko Tsukamoto

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
98 KB
Volume
119
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Loss of imprinting (LOI), the biallelic expression of an imprinting gene, of insulin‐like growth factor 2 (IGF2) has been reported to be associated with colorectal carcinogenesis because of its high prevalence in normal colorectal mucosa as well as cancerous tissue in patients with colorectal cancer. However, the characteristics of colorectal cancer associated with IGF2 LOI have not been clearly demonstrated. In this study, we investigated the IGF2 LOI status of tumor and normal mucosa in 255 consecutive patients with colorectal cancer. Of these, 95 were informative for IGF2 LOI, by direct sequencing of mRNA of IGF2. Regarding the LOI status in each patient, the prevalence of LOI in nontumorus normal mucosa was significantly higher in cases with LOI‐positive cancer than in those with LOI‐negative cancer (p < 0.001). Concerning the clinicopathological characteristics of LOI‐positive cancer, the prevalence of poorly differentiated or mucinous carcinoma (p = 0.016) and of right‐sided locations (p = 0.009) were significantly higher than those of LOI‐negative cancer. Contrary to past reports that revealed a significant correlation between microsatellite instability (MSI) and IGF2 LOI in a relatively small series of noncohort patients, our study did not find a statistically significant difference in LOI‐positive rate between MSI‐positive and ‐negative cases. Our results suggested the presence of a particular type of colorectal cancer associated with the proximal colon and poor differentiation, but independent of MSI. These results may contribute to clarification of the mechanism of colorectal tumorigenesis and to determining an appropriate screening strategy for colorectal carcinoma. © 2006 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Loss of imprinting and abnormal expressi
Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer
✍ Qing-Song Zuo; Ronglin Yan; Dian-Xu Feng; Ronghua Zhao; Chao Chen; Yi-Ming Jiang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

## Abstract This study examined the frequency of loss of imprinting (LOI) and expression of the insulin‐like growth factor 2 (__IGF2__) gene, and their relationship to selected clinical and pathological factors, in a well defined series of 90 Chinese patients with gastric cancer (GC) and 90 matched

Association of chromosome arm 16q loss w
Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor–II in Wilms tumor
✍ Stephanie K. Mummert; Victor A. Lobanenkov; Andrew P. Feinberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

## Abstract The most common known molecular defect in Wilms tumor (WT) of the kidney, the most frequent solid tumor of childhood, is loss of imprinting (LOI) of the insulin‐like growth factor–II gene (__IGF2__), which involves activation of the normally silent maternal allele of the gene and hyperm

Association of 11q loss, trisomy 12, and
Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor–II in Wilms tumor
✍ Naoki Watanabe; Hisaya Nakadate; Masayuki Haruta; Waka Sugawara; Fumiaki Sasaki; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

## Abstract We evaluated the __WT1__ and __IGF2__ status and performed chromosome and/or comparative genomic hybridization analysis in 43 tumor samples from patients with Wilms tumor. On this basis, we classified them into 4 groups: __WT1__ abnormality, loss of heterozygosity (LOH) of __IGF2__, los

Loss of imprinting of the insulin-like g
Loss of imprinting of the insulin-like growth factor II gene in mouse hepatocellular carcinoma cell lines
✍ Takao Ooasa; Hidenori Karasaki; Hiroaki Kanda; Kimie Nomura; Tomoyuki Kitagawa; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

We investigated expression of insulin-like growth factor II (Igf2) in primary cultured hepatocytes, liver epithelial (LE) cell lines derived from normal hepatocytes, and hepatocellular carcinoma (HCC) cell lines from crosses between C3H/HeJ (C3H) and Mus musculus molossinus mice (MSM). Igf2 mRNA was

Genomic imprinting of insulin-like growt
Genomic imprinting of insulin-like growth factor-2 in infant leukemia and childhood neuroblastoma
✍ Hiroyoshi Hattori; Akinobu Matsuzaki; Aiko Suminoe; Kenji Ihara; Mariko Eguchi; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

## Background: Loss of imprinting (loi) of insulin-like growth factor-2 (igf-2) has been implicated in the pathogenesis of certain human cancers and tumor-predisposing overgrowth disorders, such as beckwith-wiedemann syndrome. in a previous study, the authors revealed that certain patients with chi

Genomic imprinting of H19 and insulin-li
Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors
✍ Julie A. Ross; Peter T. Schmidt; John P. Perentesis; Stella M. Davies 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

## BACKGROUND. Insulin-like growth factor-2 (IGF2) and H19 are reciprocally imprinted genes on chromosome 11; IGF2 is expressed paternally and H19 is expressed maternally. Loss of imprinting (LOI) at both H19 and IGF2 has been reported in seven fully informative adult testicular germ cell tumors (